C4X Discovery Holdings Past Earnings Performance
Past criteria checks 3/6
C4X Discovery Holdings has been growing earnings at an average annual rate of 16%, while the Life Sciences industry saw earnings growing at 18.5% annually. Revenues have been growing at an average rate of 47.1% per year. C4X Discovery Holdings's return on equity is 42.9%, and it has net margins of 42.8%.
Key information
16.0%
Earnings growth rate
44.8%
EPS growth rate
Life Sciences Industry Growth | 36.9% |
Revenue growth rate | 47.1% |
Return on equity | 42.9% |
Net Margin | 42.8% |
Last Earnings Update | 31 Jan 2024 |
Recent past performance updates
Recent updates
Here's Why We're Watching C4X Discovery Holdings' (LON:C4XD) Cash Burn Situation
Feb 07Companies Like C4X Discovery Holdings (LON:C4XD) Are In A Position To Invest In Growth
Jul 05We're Not Very Worried About C4X Discovery Holdings' (LON:C4XD) Cash Burn Rate
Oct 07Companies Like C4X Discovery Holdings (LON:C4XD) Are In A Position To Invest In Growth
Mar 27We Think C4X Discovery Holdings (LON:C4XD) Can Afford To Drive Business Growth
Dec 12Revenue & Expenses Breakdown
How C4X Discovery Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Jan 24 | 25 | 11 | 4 | 11 |
31 Oct 23 | 13 | 0 | 4 | 11 |
31 Jul 23 | 2 | -11 | 4 | 11 |
30 Apr 23 | 3 | -9 | 4 | 11 |
31 Jan 23 | 4 | -8 | 4 | 11 |
31 Oct 22 | 4 | -8 | 4 | 10 |
31 Jul 22 | 3 | -8 | 4 | 9 |
30 Apr 22 | 4 | -6 | 4 | 9 |
31 Jan 22 | 6 | -5 | 4 | 9 |
31 Oct 21 | 6 | -4 | 3 | 9 |
31 Jul 21 | 6 | -4 | 3 | 8 |
30 Apr 21 | 3 | -6 | 3 | 7 |
31 Jan 21 | 0 | -7 | 3 | 7 |
31 Oct 20 | 0 | -8 | 3 | 7 |
31 Jul 20 | 0 | -8 | 3 | 7 |
30 Apr 20 | 0 | -9 | 3 | 8 |
31 Jan 20 | 0 | -10 | 3 | 9 |
31 Oct 19 | 0 | -10 | 3 | 10 |
31 Jul 19 | 0 | -11 | 3 | 11 |
30 Apr 19 | 4 | -7 | 3 | 10 |
31 Jan 19 | 7 | -3 | 3 | 9 |
31 Oct 18 | 7 | -2 | 3 | 8 |
31 Jul 18 | 7 | -1 | 3 | 7 |
30 Apr 18 | 4 | -4 | 3 | 7 |
31 Jan 18 | 0 | -7 | 3 | 6 |
31 Oct 17 | 0 | -7 | 3 | 6 |
31 Jul 17 | 0 | -7 | 3 | 6 |
30 Apr 17 | 0 | -6 | 2 | 6 |
31 Jan 17 | 0 | -6 | 2 | 6 |
31 Oct 16 | 0 | -5 | 2 | 5 |
31 Jul 16 | 0 | -5 | 2 | 5 |
30 Apr 16 | 0 | -5 | 2 | 5 |
31 Jan 16 | 0 | -5 | 1 | 5 |
31 Oct 15 | 0 | -4 | 1 | 4 |
31 Jul 15 | 0 | -3 | 1 | 3 |
30 Apr 15 | 0 | -2 | 1 | 2 |
31 Jan 15 | 0 | -2 | 1 | 2 |
31 Oct 14 | 0 | -1 | 1 | 1 |
31 Jul 14 | 1 | -1 | 1 | 1 |
31 Jul 13 | 1 | 0 | 1 | 0 |
Quality Earnings: C4XD has a high level of non-cash earnings.
Growing Profit Margin: C4XD became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: C4XD has become profitable over the past 5 years, growing earnings by 16% per year.
Accelerating Growth: C4XD has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: C4XD has become profitable in the last year, making it difficult to compare its past year earnings growth to the Life Sciences industry (6.5%).
Return on Equity
High ROE: C4XD's Return on Equity (42.9%) is considered outstanding.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/04/26 01:48 |
End of Day Share Price | 2024/04/26 00:00 |
Earnings | 2024/01/31 |
Annual Earnings | 2023/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
C4X Discovery Holdings plc is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Julie Simmonds | Panmure Liberum Historic (Panmure Gordon) |
Sean Conroy | Shore Capital Group Ltd |